IQ-AI subsidiary secures second orphan drug designation proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Reduced Gadolinium Approach Validated with IB Neuro on 1.5T MR Scanners itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Imaging Biometrics (IB), a subsidiary of IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), has confirmed the effectiveness of its IB Neuro technology for brain scans using.
IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging s MRI-focused IB Neuro.
IQ-AI, the Jersey-based medical services firm focused.
IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.
IQ-AI shares surged up 28% to 3.96 pence each on Friday afternoon in.